BeOne Medicines
Aaron Rosenberg, CFA, currently serves as Chief Financial Officer at BeiGene since July 2024. Prior to this role, Aaron held various senior finance positions at Merck from June 2003 to July 2024, including Senior Vice President of Finance and Corporate Treasurer, and Senior Vice President of Corporate Strategy and Planning. Aaron's earlier experience includes roles at Extended Stay America as Telecommunications and Utility Manager and at Datek Online Holdings Corp. as Financial Analyst in Corporate Development. Aaron holds an MBA in Finance from NYU Stern School of Business and a BS in Finance from the University of Florida.
This person is not in any teams
This person is not in any offices
BeOne Medicines
34 followers
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.